Aaron Wealth Advisors’s Halozyme HALO Stock Holding History

Aaron Wealth Advisors’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-827	Closed	-$33K	–	457
2022 Q1	$33K	Buy	+827	New	+$29.5K	0.01%	524

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aaron Wealth Advisors's HALO Position: Q2 2022 in Review

Aaron Wealth Advisors sold out of Halozyme (HALO) in Q2 2022, closing a stake of 827 shares — an estimated $33K sold.

Aaron Wealth Advisors first reported a position in HALO in Q1 2022 and held it in 1 quarter. The position peaked at $33K in Q1 2022. 368 funds tracked by Wall St. Rank hold HALO as of Q2 2022.

Aaron Wealth Advisors reported no remaining Halozyme position as of Q2 2022 after selling out during the quarter.
Aaron Wealth Advisors sold 827 Halozyme shares in Q2 2022, an estimated $33K.
Aaron Wealth Advisors first reported a position in Halozyme in Q1 2022 and held it in 1 quarter.
Aaron Wealth Advisors's Halozyme position peaked at $33K in Q1 2022.
368 funds tracked by Wall St. Rank held Halozyme as of Q2 2022.

Based on Aaron Wealth Advisors's 13F filing for Q2 2022, filed 22 Jul 2022.